Nexpring Health

🚨 BIG NEWS 🚨​​
The Nexpring Health booth just got a whole lot more exciting! Join the conversation with Irene Cuevas-Sáiz, MSc​ at our in-booth Vitrification and Media Workshop. With extensive experience in IVF laboratory practice, numerous scientific publications, and hands-on expertise using both culture media and vitrification technologies, Irene brings a wealth of practical and scientific knowledge to the conversation.​

Space will be limited… be sure to catch it live 👇​​
👤 Irene Cuevas-Sáiz, MSc​
📅 Monday, 6 July​
⏰ 1300-1400​
📍 Booth C12 ​

Irene Cuevas-Sáiz, MSc is the Director of the Embryology laboratory of the Hospital General Universitario of Valencia.​
No sign-up required.​

ESHRE - European Society of Human Reproduction and Embryology

Every microtool and pipette plays a role in an IVF procedure.

With ART-focused manufacturing in Pennsylvania, Belgium, and the Czech Republic, our portfolio is built to support quality, consistency, and patient outcomes.

Because when every detail matters, dependable tools make the difference.
✴️ Explore our trusted, comprehensive solutions: https://nexpringhealth.com/insights/insight/microtools-and-pipettes-rebuilt-advancing-art-manufacturing-for-consistency-and-confidence/

The right conditions change everything.�

In 1984, Planer was recognized with the Queen’s Award for Technological Achievement for our pioneering work in controlled-rate freezing. That same year, our technology played a critical role in a global milestone: the birth of the first human baby from a frozen embryo in Melbourne, Australia. Zoe Leyland’s mother had 11 embryos frozen in a Planer Controlled Rate Freezer which was developed by Planer and Professor David Pegg.�

Today, Planer’s systems are the global standard in biobanking, supporting the preservation of stem cells, tissue, and other critical biological materials. Because true innovation doesn’t just advance science – it changes lives.

Expanding what’s possible, before birth.

Our community isn’t afraid to tackle complexity. Specialized innovations like the Harrison Fetal Bladder Stent help improve outcomes at every stage of the journey, even in rare cases.

This product was also the very first to receive a Humanitarian Device Exemption from the FDA, helping define the FDA’s HDE approval pathway.

The Harrison Fetal Bladder Stent from Cook enabled early, minimally invasive intervention for fetal conditions like lower urinary tract obstruction. By helping preserve organ function and support development in utero, it marked an important step forward in fetal therapy. Because every stage of the journey matters.